Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 6 Adverse events during treatment.

From: Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study

Adverse reaction IFN gamma N = 18 Placebo N = 14
Any adverse event 12 (66.7%) 6 (42.9%)
Arthralgias 9 (50%) 2 (14.3%)
Fever 8 (44.4%) 0
Chills 6 (33.3%) 0
Anorexia 5 (27.8%) 2 (14.3%)
Asthenia 4 (22.2%) 0
Headache 3 (16.7%) 0
Diarrhea 2 (11.1%) 1 (7.1%)
Pruritus 2 (11,1%) 1 (7.1%)
Epigastralgia 1 (5.6%) 1 (7.1%)
Myalgias 0 1 (7.1%)
Vomiting 1 (5.6%) 0
Depression 0 1 (7.1%)
Anemia 1 (5.6%) 0
Pain at the injection site 1 (5.6%) 0
Increase of creatinine 1 (5.6%) 0
Limb edema 0 1 (7.1%)
Nausea 0 1 (7.1%)